Practice question

Answer the question and get instant feedback.

MediumEndocrinology & DiabetesType 2 Diabetes Mellitusukmlamrcgp aktmrcp part 1prescribing safety assessment

A 49-year-old female with T2DM on maximum oral therapy exhibits a significantly elevated HbA1c of 89 mmol/mol (10.3%). She has a BMI of 35 kg/m2 and also experiences recurrent hypoglycaemia. According to NICE, which injectable therapy might be beneficial to improve glycaemic control and aid weight loss?

Educational content. Not a substitute for clinical judgement or local policy.